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Controversial results regarding the presence and role of human papillomavirus in the development 
of oesophageal squamous cell carcinoma have been published. We used multiple broad-spectrum 
polymerase chain reactions to identify HPV DNA in oesophageal carcinomas from a low-incidence 
area. Paraffin embedded- and snap-frozen specimens from oesophageal cancer tissues of 63 patients 
were examined with a PCR technique with several primer pairs, capable of detecting most known 
HPV types. In none of the oesophagus cancer tissues could HPV DNA be detected. The role of HPV in 
this type of carcinoma in a low incidence area remains unclear. 0 1997 Elsevier Science Ltd. 
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INTRODUCTION 
SQUAMOUS CELL carcinoma of the oesophagus is a highly 
lethal disease, with striking variation in incidence in different 
parts of the world. From epidemiological surveys, it has been 
suggested that excessive alcohol intake and use of tobacco 
(especially in combination), and possibly certain nutritional 
deficiencies (vitamins A, B and C) are some of the risk fac- 
tors, but these factors alone cannot explain the very high 
incidence in some well-defined geographical areas in North 
China, Iran and South Africa. 
Human papillomaviruses (HPV) have been found to play a 
causative role in the pathogenesis of cervical dysplasia and 
cervical carcinomas. In 1978, a possible interaction between a 
bovine papillomavirus (BP4) and an environmental carcino- 
gen (bracken fern) was regarded as an important event for the 
development of squamous cell carcinomas, especially of the 
oesophagus, in cattle grazing on the Scottish Highlands [l]. 
Syrianen suggested in 1982 for the first time a possible 
aetiological relationship between HPV and benign prolifera- 
tions of the squamous mucous membrane of the oesophagus, 
for instance, papillomas [2]. In the animal model of bovine 
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papillomavirus infection, these lesions have been reported to 
undergo malignant transformation following exposure to car- 
cinogens. Winkler and associates in 1985 reported the clini- 
cal, histological and morphological features of Hl?V infection 
in cases of benign oesophageal proliferations, while at the 
same time a role of HPV infection in carcinoma of the oeso- 
phagus in black South Africans was suggested [3,4]. In both 
studies, HPV antigens could be detected by means of immu- 
noperoxidase techniques in 30% of those cases in which the 
histological criteria of HPV infection were met. Since then, a 
number of controversial studies have been published about 
the detection of HPV DNA in human oesophageal cancer 
with different techniques. Positive results were obtained 
mainly in high-incidence areas. In The Netherlands, 
squamous cell cancer of the oesophagus is a rare disease. We 
investigated the presence of HPV DNA in oesophageal can- 
cer from a low-incidence area using multiple, very sensitive, 
broad-spectrum polymerase chain reaction (PCR) tech- 
niques. 
MATERIALS AND METHODS 
We investigated formalin-fixed, paraffin-embedded tumour 
specimens of 63 consecutive patients with operable invasive 
squamous or undifferentiated large cell carcinoma of the 
oesophagus, who participated in a phase III randomised 
clinical trial of surgery with (n= 21) or without (n= 42) 
1865 
1866 T.C. Kok et al. 
neoadjuvant chemotherapy. This study was carried out in the 
largest referral centre for oesophageal cancer patients in The 
Netherlands (age-adjusted death rate of oesophageal cancer: 
7.9/100 000 for males and 3.2/100 000 for females). In 20 out 
of 42 patients treated with surgery alone, we also investigated 
snap-frozen specimens, collected and frozen in liquid nitro- 
gen within 1 h after surgical removal. All available haematox- 
ylin and eosin stained sections were reviewed, and the most 
representative block was selected for further studies. Patient 
characteristics are listed in Table 1. No patient had a history 
of or a presence of active papillomas of any site in the head 
and neck or oesophagus region. 
To extract DNA from paraffin-embedded tissue, 5 pm 
sections were cut, taking care to prevent cross-contamination, 
and incubated in 300~1 1OmM Tris-HCl @H 8.9), 5OmM 
KCl, 2.5 mM MgCla and 0.5% Tween-80 with 200ug/ml 
proteinase K at 56°C for 18 h. At the end of the incubation, 
the aqueous phase was separated from the paraffin slurry by 
centrifugation, transferred to a fresh tube and the proteinase 
K was subsequently inactivated by boiling. Frozen tissue 
specimens were sliced using a cryomicrotome and two 5 pm 
sections were used for the preparation of DNA. To extract 
DNA, the slices were incubated for 4 h at 56°C with 200 pg/ 
ml proteinase K in 200 ul 50mM Tris-HCl (pH8.9) and 
1 mM EDTA. After completion of the digestion, the pro- 
teinase K was heat inactivated. 
For analysis of the presence of HPV DNA, 5 ul of each 
sample was subjected to 40 cycles of PCR amplification in 
50~1 reactions using each of the following primer sets: (1) 
MY09 (S’CGT CC&A/C) A(A/G)A GGG A(AiT)A CTG 
ATC) and MY11 (S’GC(A/C) CAG GG(A!T) CAT AA(C/ 
T) AAT GG) [5]; (2) GP5 (S’TTT GTT ACT GTG CTA 
GAT AC) and GP6 (STGA TIT ACA GTT TAT TTI 
TC) [6]; (3) CPI (5’TTA TCA (T/A)AT GCC CA(T/C) 
TGT ACC AT) and CPIIG (5’ATG TTA AT(m) (G/ 
C)AG CC(AfT) CCA AAA TT) [7,8]; (4) CPI and CPIIS 
(5’ATA T-TG TCT GAG CCT CC(AT) AA(A/G) I-T) [9] 
and (5) Pulm (S’TGT CAA AAA CCG TTG TGT CC) and 
Pu2r (S’GAG CTG TCG GCT TA4 TTG CTC) [IO]. 
Amplification was also done using a nested PCR approach 
using the MYO9/11 primer set in the first and the GP5/6 pri- 
mer set in the second PCR. Each of these primer pairs was 
designed for the amplification of spectra of genital HPV types 
Table 1. Patient and tumour characteristics (n = 63) 
Median age 
Gender 
male 
female 
Race 
Caucasian 
Black 
Chinese 
Grade of differentiation 
well 
moderately 
poor 
undifferentiated 
Stage (UICC) 
I 
II 
III 
IV 
63.5 years (35-77 years) 
48 
15 
60 
2 
1 
7 
38 
17 
1 
6 (10%) 
26 (41%) 
10 (16%) 
21 (33%) 
with the exception of the CPFIIS primers set, which was 
developed for the detection of HPV types present in the skin. 
The MYO9/11, GP5/6, Pulm/%r and CPI/IIG PCRs were 
performed under the conditions described in the original 
publications including the appropriate positive (SiHa DNA) 
and negative controls [5-7,9, lo]. In addition, we used a 
nested PCR method directed by two novel primer pairs spe- 
cifically designed for the sensitive amplification of HPV types 
present in the skin lesions of epidermodysplasia verucifonnis 
patients [l 11. The nucleotide sequence of the two primers 
used in the first PCR are S’CA(A/G) GGT CA(C/T) AA(C/ 
T) AAT GG(CiT) AT (CP65) and 5’AA(CiT) TIT CGT 
CC(CiT) A(A/G)A G(A/G)A (AiT)AT (CP70), and those of 
the two primers used in the nested PCR are 5’AAT CA(A/G) 
(A/C)TG TIT (A/G)TT AC(AfI) GT (CP66) and 5’G(Al 
T)T AGA TC(A/T) ACA T(CiT)C CA(A/G) AA (CP69). 
In a separate reaction, a @globin PCR was carried out 
using two pairs of primers; either PC03 @o-l) and RS42 
amplifying a 441 bp fragment or glo-1 (5’ACACAACTGT- 
GTICACTACC) and glo-3 (5’TCTATTGGTCTCC- 
TTAAACC) amplifying a 172 bp fragment. Successful 
amplification of the P-globin fragment, visualised on an 
ethidium-stained agarose gel, indicated that the sample was 
adequate for PCR analysis. 
RESULTS 
None of the different PCR reactions resulted in the detec- 
tion of HPV DNA in the oesophageal carcinoma specimens 
when the PCR products were analysed by ethidium bromide 
stained agarose gels (Figure 1). Also no specific signals were 
detected after blotting and hybridisation of the PCR products 
of the MY09/11 PCR, the GP5/6 PCR and the CPFIIG PCR 
with mixtures of PCR labelled probes. These primer pairs 
combined are capable of detecting most known HPV types. 
78 and 79 of a total of 83 samples were positive when ana- 
lysed by PCR with the two P-globin primer pairs producing a 
441 and 17 1 bp fragment, respectively (Figure 1 (d)). This 
indicates that almost all DNA preparations were adequate for 
PCR analysis. 
DISCUSSION 
We investigated a possible role of HPV in the pathogenesis 
of squamous cell carcinoma of the oesophagus in patients 
from a low-incidence area. In this material, of which 95% of 
the specimens were proven to be suitable for PCR analysis, 
we could not detect any HPV DNA. These results strongly 
suggest that HPV DNA of the known HPV types is not pre- 
sent in at least the majority of the oesophageal squamous cell 
carcinomas in The Netherlands. We cannot exclude the pos- 
sibility that novel HPV types, which do not match the PCR 
primers used, are present. Recently, we succeeded in detect- 
ing novel HPV types in skin lesions of immunocompromised 
patients by PCR amplification, employing a nested PCR 
approach using the primer sets CP65/66 and CP69/70 [ 111. 
Data from the literature on HPV, relating to benign and 
malignant oesophageal lesions, are conflicting [ 121. In a study 
from Australia, with DNA hybridisation techniques, using a 
mixed probe of HPV types 11, 13, 16 and 18, an overt posi- 
tive reaction in 2, and a weak positive reaction in 3 out of 10 
cases of oesophageal squamous cell carcinomas could be 
demonstrated, whereas no detectable viral antigen in these 
cases was found, suggesting that detection of the genome is 
more sensitive than immunostaining [13]. In 1990 the same 
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Figure 1. Absence of HPV DNA corn oesophageal carcino- 
mas. Ten pl of the PCR products of 5 tumours (lanes 1-5) and 
SiHa cells containing 1-2 copies of HPV-16 DNA per cell (lane 
6) were run on a ethidimn bromide stained agarose gel. Lane 
m: 100 bp ladder marker. The band of the positive control 
(lane 6) indicates the position of expected HPV amplimers. 
Amplimers of the PCR directed by (a) GPS16 primers, (b) CPU 
IIG primers, (c) Pulm/Zr primers, (d) Glo-l/Glo-3 primers. 
author published his results on the positive detection of HPV 
type 6, 11, 16 and 18 DNA by filter in situ hybridisation 
(FISH) techniques in 9 out of 39 oesophageal cancers from a 
low-incidence area [14]. Chang and associates reported in 
1990 positive results with the same method in oesophageal 
cytologic specimens from a high-risk area, ranging from aty- 
pia to invasive squamous cell carcinoma, including lesions 
adjacent to the tumour area [ 151. In 75% of positive cases, 
HPV type 16 and/or 18 DNA sequences were found. These 
findings were confirmed in several other reports, especially 
from high-risk areas, such as South Africa, Japan, China and 
France [16-181. The largest series to date was published in 
1993 by Chang and associates [19]. In this study, biopsy 
specimens of tumour, adjacent epithelia, regional lymph 
nodes and surgically resected margins were collected from 
363 patients surgically treated with oesophagectomy for 
invasive squamous cell carcinoma in the high-risk area of 
Linxian, China. In 20% of cases, positive signals were found 
in the nuclei of cancer cells by in situ hybridisation, in 4% 
only in the adjacent epithelium with hyperplastic or dysplastic 
changes, and in only 1 case in the resected margin. HPV type 
16 was the most common finding in the 85 positive cases 
[20]. The presence of positive hybridisation signals in regio- 
nal lymph node metastases (12.3%), exclusively confined to 
the nuclei of metastatic cancer cells, suggests a causal asso- 
ciation of HPV and oesophageal carcinoma in these patients, 
more so because the same viral type was invariably detected 
in both the primary tumour and the metastatic lesions. 
Cooper and associates demonstrated the presence of HPV 
DNA in 25 of 48 oesophageal cancers from a high-risk area 
(South Africa), utilising non-isotopic in situ hybridisation 
with HPV DNA probes to HPV 6,11, 16 18,31 and 33 [21]. 
Very recently, Dillner and associates found an association 
between seropositivity to HPV type 16 and the risk of oeso- 
phageal cancer in Finland [22]. 
In contrast to these data, negative results have also been 
reported, especially in low-risk areas, but also in high-risk 
areas [23-261. Lake and associates applied both in situ 
hybridisation and DNA slot blot analysis to a series of 37 
cases where total oesophagectomy was performed for 
squamous cell carcinoma in the high-incidence area of Hong 
Kong. With both techniques no HPV was detectable in can- 
cer cells nor in intra-epithelial neoplasia nor in normal oeso- 
phageal mucosa. Kiyabu and associates used in vitro gene 
amplification by the polymerase chain reaction to look for 
HPV type 16 and 18 DNA in invasive squamous cell cancers 
of various types [23]. While 70% of the ano-genital carcino- 
mas, and 36% of the oropharyngeal carcinomas contained 
HPV DNA sequences, none of 13 oesophageal carcinomas 
were found to be positive. Our own results from a low-inci- 
dence area are consistent with these studies. 
There are several complicating issues when comparing 
studies about HPV detection in benign and malignant tissues. 
In high-risk areas, a possible influence of screening methods 
regarding the stage of the tumour at the time of diagnosis 
could exist. It is important to realise that several authors 
found HPV DNA in the epithelium, adjacent to the carci- 
noma, more than in the cancer itself [ 161. This phenomenon 
is consistent with the earlier findings that bovine papilloma- 
virus type 4 DNA in high copy number could be readily 
identified in bovine papillomas, but no viral DNA nor viral 
antigens could be detected in malignant lesions, indicating 
that viral genomes are not necessary to maintain a malignant 
state. 
A second issue is the methodology. Using amplification by 
the polymerase chain reaction, it is possible to detect HPV 
genomes with high sensitivity, for instance up to less than 
10-l copies of viral genome per cell, which is superior com- 
pared to the older hybridisation techniques and immuno- 
staining techniques [ 14,151. We used in our study several 
pairs of general primer sequences, which are conserved 
among a broad spectrum of HPV types, and which permit the 
detection of more HPV types in a single sample. Also poten- 
tially new HPV types can be identified by these methods. 
In conclusion, in our study with oesophageal squamous 
cell cancer specimens from a low-incidence area, we could 
not confirm the results of some other investigators, iden- 
tifying HPV DNA in oesophageal carcinomas, mainly type 
16 and 18. In this respect, our results are identical to 
those described by Loke, Kiyabu, Sugimachi and Akutsu 
[22,24-261. 
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